Trial intelligence / Profile preview

DS-1971a in healthy male subjects

NCT02190058Phase 1Completed

Sponsor
Daiichi Sankyo Co., Ltd.
Start
Jul 2014
Primary completion
Nov 2014
Countries
1
01

Overview

Phase 1, randomised, double-blind trial in neuropathic pain comparing DS-1971a with Placebo (2 arms). Primary endpoint: Adverse events at 2 months. Started Jul 2014; status: completed.

02

Drugs

DS-1971
03

Conditions

neuropathic pain

Beyond the preview

Go deeper on NCT02190058.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02190058.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call